GMP-production of an allogenic DC-based cancer vaccine (INTUVAX) for treatment of patients with metastatic kidney-or primary liver cancer. Comparison of two production platforms for DC-generationVise andre og tillknytning
2016 (engelsk)Inngår i: European Journal of Immunology, ISSN 0014-2980, E-ISSN 1521-4141, Vol. 46, s. 946-947Artikkel i tidsskrift, Meeting abstract (Annet vitenskapelig) Published
sted, utgiver, år, opplag, sider
2016. Vol. 46, s. 946-947
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-308496ISI: 000383610402295OAI: oai:DiVA.org:uu-308496DiVA, id: diva2:1050006
Konferanse
International Congress of Immunology (ICI), AUG 21-26, 2016, Melbourne, AUSTRALIA
2016-11-282016-11-282018-01-13bibliografisk kontrollert